Market Overview

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX)

37.16 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2020
Pre-Market
EPS:
REV:




Q1 2020
Pre-Market
EPS:
REV:
0.22
91.313M



Q4 2019
Pre-Market
EPS:
REV:
0.47
95.115M



Q3 2019
Pre-Market
EPS:
REV:
0.31
83.448M



Q2 2019
Pre-Market
EPS:
REV:
0.24
84.107M
0.34
100.52M
0.41
102.604M
20.59%
2.07%
Q1 2019
Pre-Market
EPS:
REV:
0.02
74.607M
0.26
92.1M
0.22
91.313M
-15.38%
-0.85%
Q4 2018
Pre-Market
EPS:
REV:
0.38
79.078M
0.28
93.69M
0.47
95.115M
67.86%
1.52%
Q3 2018
Pre-Market
EPS:
REV:
0.11
67.335M
0.08
80.18M
0.31
83.448M
287.5%
4.08%
Q2 2018
Pre-Market
EPS:
REV:
-0.11
70.934M
0.07
78.86M
0.24
84.107M
242.86%
6.65%
Q1 2018
Pre-Market
EPS:
REV:
-0.19
69.283M
0.01
73.93M
0.02
74.607M
100%
0.92%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!